This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Weber, W.W., and Hein, D.W., 1985, N-acetylation pharmacogenetics. Pharmacol. Rev. 37: 25–79.
Chen, M.L., Lee M.G., and Chiou W.L., 1983, Pharmacokinetics of drugs in blood III: Metabolism of procainamide and storage effects of blood samples. J. Pharma. Sci. 72: 572–574.
Sharquie, K.E., 1990, Behçet’s disease. Postgrad. Doctor Middle East 13: 186–190.
Behçet, H., 1937, Über rezidivierende aphthöse, durch ein virus verursachte Geschwüre am Mund am Auge und den Genitalien. Dermatol. Wochenschr. 105: 1152–1157.
Sharquie K., 1984, Suppression of Behçet’s disease with dapsone. Br. J. Dermatol. 110: 493–494.
Sharquie, K., Najim, R.A., and Abu-Raghif, A.R., 2002, Dapsone in treatment of Behçet’s disease: a double blind, placebo-controlled crossover study. J. Dermatol., in press.
International Study Group for Behçet’s disease, 1990, Criteria for diagnosis of Behçet’s disease. Lancet 335: 1078–1080.
Philip, P.A., Gayed, S.L., and Rogers, H.J., 1984, A rapid method for determination of acetylation phenotype using dapsone. Br. J. Clin. Pharmacol. 17: 465–469.
Sorlie, D.E., 1995, Medical Biostatistics and Epidemiology: Examination and Board review. 1st ed., Appleton and Lange, Norwalk, Connecticut, pp. 47–88.
Friedman, J.M., 1996, Population genetics. In Genetics (Friedman, J.M., ed.), 2nd ed., pp. 105–111.
Ahmad, R.A., 1984, Acetylation in Iraqi population. In Proceeding of the First Scientific Congress, College of Medicine, University of Baghdad, p. 115.
Irashaid, Y.M., Al-Hadidi H.F., Aburijeie, M.A., et al., 1991, N-acetylation phenotyping using dapsone in a Jordanian population. Br. J. Clin. Pharmacol. 32: 289–293.
Islam, S.I., 1982, Polymorphic acetylation of sulphamethazine in rural Bedouin and urban dwellers in Saudi Arabia. Xenobiotica 12: 323–328.
Karim, A.K.M.B., Elferah, M.S., and Evans, D.A.P., 1981, Human acetylator polymorphism: estimate of allele frequency in Libya and details of global distribution. J. Med. Genet. 18: 325–330.
Hashem, N., Khalifa, S., and Nour, A., 1969, The frequency of isoniazide acetylase enzyme deficiency among Egyptians. Am. J. Phys. Anthropol. 31: 97–102.
Grant, D.M., Tang, B.K., and Kalow, W., 1983, Polymorphic N-acetylation of a caffeine metabolite. Clin. Pharmacol. Ther. 33: 355–359.
Horai, Y., and Ishizaki, T., 1988, N-acetylation polymorphism of dapsone in a Japanese population. Br. J. Clin. Pharmacol. 25: 487–494.
El-Yazigi, A., Chaleby, K., and Martin, C.R., 1989, Acetylator phenotypes of Saudi Arabians by a simplified caffeine metabolites test. J. Clin. Pharmacol. 29: 246–250.
Yazici, H., Chamberlain, M.A., Schreuder, T., et al., 1980, HLA antigen in Behçet’s disease: A reapprasial by a comperative study of Turkish and British patients. Ann. Rheum. Dis. 39: 344.
Al-Rawi, Z.S., Sharquie, K.E., Khalifa, S.J., et al., 1986, Behçet’s disease in Iraqi patients. Ann. Rheum. Dis. 45: 987–990.
Evans D.A.P., Manley K.A., and Mckusick, V.A., 1960, Genetic control of isoniazide metabolism in man. Br. Med. J. 2: 458–491.
Zuidema, J., Hilbers, E.S., and Merkus A., 1986, Clinical pharmacokinetics of dapsone. Clin. Pharmacokinet. 11: 299–314.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2004 Kluwer Academic Publishers
About this chapter
Cite this chapter
Najim, R.A., Sharquie, K.E., Al-Janabi, M.H. (2004). Acetylator Phenotype in Behçet’s Disease. In: Zouboulis, C.C. (eds) Adamantiades-Behçet’s Disease. Advances in Experimental Medicine and Biology, vol 528. Springer, Boston, MA. https://doi.org/10.1007/0-306-48382-3_26
Download citation
DOI: https://doi.org/10.1007/0-306-48382-3_26
Publisher Name: Springer, Boston, MA
Print ISBN: 978-0-306-47757-7
Online ISBN: 978-0-306-48382-0
eBook Packages: Springer Book Archive